These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21944023)
1. The role of chemotherapy and targeted agents in patients with metastatic breast cancer. Johnston SR Eur J Cancer; 2011 Sep; 47 Suppl 3():S38-47. PubMed ID: 21944023 [TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic approaches to the treatment of metastatic breast cancer. Fernández Y; Cueva J; Palomo AG; Ramos M; de Juan A; Calvo L; García-Mata J; García-Teijido P; Peláez I; García-Estévez L Cancer Treat Rev; 2010 Feb; 36(1):33-42. PubMed ID: 19883980 [TBL] [Abstract][Full Text] [Related]
3. Introduction: Current and future approaches to chemotherapy in patients with resistant breast cancer. Burstein HJ Semin Oncol; 2011 Jun; 38 Suppl 2():S1-2. PubMed ID: 21600379 [No Abstract] [Full Text] [Related]
4. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response. Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676 [TBL] [Abstract][Full Text] [Related]
5. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors. Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N; Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010 [TBL] [Abstract][Full Text] [Related]
6. Other options in the treatment of advanced breast cancer. Cobleigh MA Semin Oncol; 2011 Jun; 38 Suppl 2():S11-6. PubMed ID: 21600380 [TBL] [Abstract][Full Text] [Related]
7. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors. Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319 [TBL] [Abstract][Full Text] [Related]
8. Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer. Johnston S; Pippen J; Pivot X; Lichinitser M; Sadeghi S; Dieras V; Gomez HL; Romieu G; Manikhas A; Kennedy MJ; Press MF; Maltzman J; Florance A; O'Rourke L; Oliva C; Stein S; Pegram M J Clin Oncol; 2009 Nov; 27(33):5538-46. PubMed ID: 19786658 [TBL] [Abstract][Full Text] [Related]
9. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
10. [Targeted based therapies in metastatic breast cancer: future evolution]. Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P Therapie; 2012; 67(6):491-503. PubMed ID: 23249575 [TBL] [Abstract][Full Text] [Related]
11. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer. Awada A Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for metastatic breast cancer. Nabholtz JM; Reese DM; Lindsay MA; Riva A Expert Rev Anticancer Ther; 2002 Apr; 2(2):169-80. PubMed ID: 12113239 [TBL] [Abstract][Full Text] [Related]
14. Maintenance treatment in metastatic breast cancer. Sánchez-Muñoz A; Pérez-Ruiz E; Ribelles N; Márquez A; Alba E Expert Rev Anticancer Ther; 2008 Dec; 8(12):1907-12. PubMed ID: 19046111 [TBL] [Abstract][Full Text] [Related]
15. An overview of contemporary management of breast carcinoma. Suhrland LG Obstet Gynecol Clin North Am; 1987 Sep; 14(3):783-96. PubMed ID: 3323974 [TBL] [Abstract][Full Text] [Related]
16. The next generation of biologic agents: therapeutic role in relation to existing therapies in metastatic breast cancer. Conte P; Guarneri V Clin Breast Cancer; 2012 Jun; 12(3):157-66. PubMed ID: 22607765 [TBL] [Abstract][Full Text] [Related]
17. Survival data of patients with anthracycline- or taxane-pretreated or resistant metastatic breast cancer. Barnett CM Pharmacotherapy; 2009 Dec; 29(12):1482-90. PubMed ID: 19947807 [TBL] [Abstract][Full Text] [Related]
18. Has first-line therapy had an impact on general outcome in metastatic breast cancer? McArthur HL; Hudis CA Future Oncol; 2007 Aug; 3(4):411-8. PubMed ID: 17661716 [TBL] [Abstract][Full Text] [Related]
19. Survival impact of integrative cancer care in advanced metastatic breast cancer. Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J Breast J; 2009; 15(4):357-66. PubMed ID: 19470134 [TBL] [Abstract][Full Text] [Related]
20. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy. Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O; Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]